Talk:Opportunistic infection
 | This  level-5 vital article is rated Start-class on Wikipedia's content assessment scale.It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Opportunistic infection.
|
Wiki Education Foundation-supported course assignment
edit
This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 January 2021 and 15 March 2021. Further details are available on the course page. Student editor(s): Immcarle140.
Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 05:46, 17 January 2022 (UTC)
Hello, I am a fourth-year medical student participating in the WikiMed course at my university. I’m excited to be able to participate in this article and would welcome any suggestions or advice for my following edits. I am mainly focused on the prophylactic medication section. I want to add other infections we should be aware of when starting prophylactic medications. I also want to add more information on the indication sections, as CD4 count is not the only indication to start prophylactic medication. I want to add a new section discussing when it is appropriate to discontinue the medication. And finally, I want to update and add alternative medications when suggesting the agent.
Below is the bibliography, where I will be referring to the information. Thank you in advance for your suggestions and advice.
https://www.eacsociety.org/media/final2021eacsguidelinesv11.0_oct2021.pdf --> EU society guidelines for opportunistic infections, last updated in 2021
https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-oi/guidelines-adult-adolescent-oi.pdf --> CDC and NIH guidelines for opportunistic infections, updated regularly
https://www.ncbi.nlm.nih.gov/books/NBK567851/pdf/Bookshelf_NBK567851.pdf --> New York clinical guideline for HIV care, updated in 2021
15:51, 16 February 2023 (UTC) — Preceding unsigned comment added by Gmoren5 (talk • contribs)
Bibliography
editI'm going to be editing this page as part of a WikiEducation project--here are some sources that I'll be working with over the coming weeks.
Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., and Talbot, P.J. (2019). Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses 12, 14. doi.org/10.3390/v12010014
Hijano, D.R., Maron, G., and Hayden, R.T. (2018). Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant. Front. Microbiol. 9, 3097. doi.org/10.3389/fmicb.2018.03097
José, R.J., Periselneris, J.N., and Brown, J.S. (2020). Opportunistic bacterial, viral and fungal infections of the lung. Medicine 48, 366–372. doi.org/10.1016/j.mpmed.2020.03.006
Sedghizadeh, P.P., Mahabady, S., and Allen, C.M. (2017). Opportunistic Oral Infections. Dental Clinics of North America 61, 389–400. doi.org/10.1016/j.cden.2016.12.007
Youssef, J., Novosad, S.A., and Winthrop, K.L. (2016). Infection Risk and Safety of Corticosteroid Use. Rheumatic Disease Clinics of North America 42, 157–176. doi.org/10.1016/j.rdc.2015.08.004 — Preceding unsigned comment added by Immcarle140 (talk • contribs) 03:27, 30 January 2021 (UTC)